Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Key points: Reducing free fatty acids in the circulation gives protection against muscle insulin resistance. In the present study, we investigated the mechanism by which free fatty acid reduction improves muscle insulin sensitivity. The antilipolytic drug acipimox reduced the plasma concentration of unsaturated and saturated fatty acids in insulin‐resistant (obese and type 2 diabetic) subjects. The reduction in plasma free fatty acid concentration caused by acipimox led to an improvement in local inflammation and insulin signalling in skeletal muscle. The improvements in local inflammation and insulin signalling were more pronounced in obese type 2 diabetic subjects than obese non‐diabetic individuals, suggesting that diabetic subjects are more susceptible to the toxic effect of circulating free fatty acids. Abstract Free fatty acids (FFAs) have been implicated in the pathogenesis of insulin resistance. Reducing plasma FFA concentration in obese and type 2 diabetic (T2DM) subjects improves insulin sensitivity. However, the molecular mechanism by which FFA reduction improves insulin sensitivity in human subjects is not fully understood. In the present study, we tested the hypothesis that pharmacological FFA reduction enhances insulin action by reducing local (muscle) inflammation, leading to improved insulin signalling. Insulin‐stimulated total glucose disposal (TGD), plasma FFA species, muscle insulin signalling, IκBα protein, c‐Jun phosphorylation, inflammatory gene (toll‐like receptor 4 and monocyte chemotactic protein 1) expression, and ceramide and diacylglycerol (DAG) content were measured in muscle from a group of obese and T2DM subjects before and after administration of the antilipolytic drug acipimox for 7 days, and the results were compared to lean individuals. We found that obese and T2DM subjects had elevated saturated and unsaturated FFAs in plasma, and acipimox reduced all FFA species. Acipimox‐induced reductions in plasma FFAs improved TGD and insulin signalling in obese and T2DM subjects. Acipimox increased IκBα protein (an indication of decreased IκB kinase–nuclear factor κB signalling) in both obese and T2DM subjects, but did not affect c‐Jun phosphorylation in any group. Acipimox also decreased inflammatory gene expression, although this reduction only occurred in T2DM subjects. Ceramide and DAG content did not change. To summarize, pharmacological FFA reduction improves insulin signalling in muscle from insulin‐resistant subjects. This beneficial effect on insulin action could be related to a decrease in local inflammation. Notably, the improvements in insulin action were more pronounced in T2DM, indicating that these subjects are more susceptible to the toxic effect of FFAs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 1×
“Skeletal muscle insulin resistance is one of the earliest abnormalities in the natural history of type 2 diabetes mellitus (T2DM) (Lillioja et al. 1988; Warram et al. 1990; DeFronzo & Tripathy, 2009).”
BackgroundSelf-citationYu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 5×
“Another model proposes that FFAs and the intramyocellular metabolism of FFAs and triglycerides lead to the accumulation of toxic metabolites such as ceramide and diacylglycerol (DAG) which impair insulin signalling (Summers et al. 1998; Yu et al. 2002).”
BackgroundInfluentialMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · cited 1×
“After a 10–12 h overnight fast, subjects underwent a baseline vastus lateralis muscle biopsy as described previously (Cusi et al. 2000) using a modified Bergstrom technique.”
MethodSelf-citationWarram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Fatty acids, obesity, and insulin resistance: Time for a reevaluation
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011) · Diabetes · doi:10.2337/db11-0425 · Cited by 896 · cited 2×
“Obese non-diabetic subjects also are reported to have an increased plasma FFA concentration, although the magnitude of the increase is less severe than that seen in T2DM individuals (∼70 μM higher than lean individuals) (Karpe et al. 2011).”
BackgroundHolland, W. L., Bikman, B. T., Wang, L.-P., Yuguang, G., Sargent, K. M., Bulchand, S., Knotts, T. A., Shui, G., Clegg, D. J., Wenk, M. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43378 · Cited by 705 · cited 1×
“Similar to LPS, saturated FFAs from a metabolic/nutritional source, such as palmitic acid, also activate TLR4 and impair insulin action (Shi et al. 2006; Reyna et al. 2008; Holland et al. 2011).”
BackgroundBoden, G., Lebed, B., Schatz, M., Homko, C., & Lemieux, S. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1612 · Cited by 597
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578 · cited 1×
“Skeletal muscle insulin resistance is one of the earliest abnormalities in the natural history of type 2 diabetes mellitus (T2DM) (Lillioja et al. 1988; Warram et al. 1990; DeFronzo & Tripathy, 2009).”
BackgroundMetabolic flexibility and insulin resistance
Galgani, J. E., Moro, C., & Ravussin, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90558.2008 · Cited by 532 · cited 1×
“Decreased mitochondrial function has been proposed as a key determinant of metabolic inflexibility in insulin-resistant muscle (Galgani et al. 2008), although direct evidence supporting this concept is lacking.”
BackgroundSantomauro, A. T., Boden, G., Silva, M. E., Rocha, D. M., Santos, R. F., Ursich, M. J., Strassmann, P. G., & Wajchenberg, B. L. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1836 · Cited by 431
IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle
Steensberg, A., Keller, C., Starkie, R. L., Osada, T., Febbraio, M. A., & Pedersen, B. K. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00255.2002 · Cited by 410 · cited 5×
“Another model proposes that FFAs and the intramyocellular metabolism of FFAs and triglycerides lead to the accumulation of toxic metabolites such as ceramide and diacylglycerol (DAG) which impair insulin signalling (Summers et al. 1998; Yu et al. 2002).”
BackgroundInfluentialDose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., DeFronzo, R. A., & Cusi, K. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1640 · Cited by 404 · cited 1×
“…the role of FFA in insulin resistance stems from numerous studies demonstrating that an experimental elevation of plasma FFA concentration impairs peripheral (muscle) insulin sensitivity in normal glucose-tolerant (NGT) subjects (Boden et al. 2001; Itani et al. 2002; Belfort et al. 2005).”
BackgroundSelf-citationHøeg, L. D., Sjøberg, K. A., Jeppesen, J., Jensen, T. E., Frøsig, C., Birk, J. B., Bisiani, B., Hiscock, N., Pilegaard, H., Wojtaszewski, J. F. P., et al. (2011) · Diabetes · doi:10.2337/db10-0698 · Cited by 136 · cited 1×
“…by Hoeg et al. in healthy volunteers showed that a 7 h intralipid infusion caused insulin resistance without affecting muscle DAG and ceramide content (Hoeg et al. 2011), although increased muscle DAG levels have been reported by others following lipid infusion (Itani et al. 2002; Yu et al. 2002).”
BackgroundGhosh, S., Lertwattanarak, R., Lefort, N., Molina-Carrion, M., Joya-Galeana, J., Bowen, B. P., Garduno-Garcia, J. D. J., Abdul-Ghani, M., Richardson, A., DeFronzo, R. A., et al. (2011) · Diabetes · doi:10.2337/db11-0121 · Cited by 128
Self-citationBajaj, M., Suraamornkul, S., Kashyap, S., Cusi, K., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0224 · Cited by 109
Self-citationKrag, M. B., Gormsen, L. C., Guo, Z., Christiansen, J. S., Jensen, M. D., Nielsen, S., & Jørgensen, J. O. L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2006 · Cited by 101
Cited by
Adipocyte lipolysis and insulin resistance
Morigny, P., Houssier, M., Mouisel, E., & Langin, D. (2016) · Biochimie · doi:10.1016/j.biochi.2015.10.024 · Cited by 469
Rivas, D. A., McDonald, D. J., Rice, N. P., Haran, P. H., Dolnikowski, G. G., & Fielding, R. A. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00198.2015 · Cited by 132
“Increases in the inflammatory components, such as I B , TLR2, IL-1 , and TNF- were only observed with aging and not obesity.”
InfluentialMitochondrial dynamics in skeletal muscle insulin resistance and type 2 diabetes
Fealy, C. E., Mulya, A., Axelrod, C. L., & Kirwan, J. P. (2018) · Translational Research · doi:10.1016/j.trsl.2018.07.011 · Cited by 63
Physical Exercise and Metabolic Reprogramming
Batatinha, H. P., Lira, F. S., Kruger, K., & Rosa Neto, J. C. (2022) · Essential Aspects of Immunometabolism in Health and Disease · doi:10.1007/978-3-030-86684-6_12 · Cited by 5
Metadata
- Authors
- Liang, H., Tantiwong, P., Sriwijitkamol, A., Shanmugasundaram, K., Mohan, S., Espinoza, S., DeFronzo, R. A., Dubé, J. J., & Musi, N.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2013-05-03
- Volume
- 591
- Issue
- 11
- Pages
- 2897-2909
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2155159580
- Cited by
- 59
- References
- 18
- FWCI
- 4.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.